JPH08503136A - Ｐ．ｍｕｌｔｏｃｉｄａによるパスツレラ症に対する感染防御剤 - Google Patents

Ｐ．ｍｕｌｔｏｃｉｄａによるパスツレラ症に対する感染防御剤

Info

Publication number
JPH08503136A
JPH08503136A JP6512199A JP51219994A JPH08503136A JP H08503136 A JPH08503136 A JP H08503136A JP 6512199 A JP6512199 A JP 6512199A JP 51219994 A JP51219994 A JP 51219994A JP H08503136 A JPH08503136 A JP H08503136A
Authority
JP
Japan
Prior art keywords
toxic
multocida
mutant
transposon
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6512199A
Other languages
English (en)
Japanese (ja)
Inventor
チェ、キウム・フワ
マヒズワラン、サムエル・ケイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota
Original Assignee
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota filed Critical University of Minnesota
Publication of JPH08503136A publication Critical patent/JPH08503136A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP6512199A 1992-11-06 1993-11-05 Ｐ．ｍｕｌｔｏｃｉｄａによるパスツレラ症に対する感染防御剤 Pending JPH08503136A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97307092A 1992-11-06 1992-11-06
US07/973,070 1992-11-06
PCT/US1993/010600 WO1994011024A1 (en) 1992-11-06 1993-11-05 Composition protective against p. multocida pasteurellosis infection

Publications (1)

Publication Number Publication Date
JPH08503136A true JPH08503136A (ja) 1996-04-09

Family

ID=25520459

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6512199A Pending JPH08503136A (ja) 1992-11-06 1993-11-05 Ｐ．ｍｕｌｔｏｃｉｄａによるパスツレラ症に対する感染防御剤

Country Status (5)

Country Link
EP (1) EP0668779A4 (de)
JP (1) JPH08503136A (de)
AU (1) AU5591694A (de)
CA (1) CA2148829A1 (de)
WO (1) WO1994011024A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76975A (hu) 1994-12-09 1998-01-28 Imperial College Innovations Limited Eljárás gének azonosítására
CA2341349C (en) 1998-09-04 2013-12-10 Creatogen Aktiengesellschaft Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
AU2010201539C1 (en) * 1999-04-09 2016-06-16 Zoetis Services Llc Anti-bacterial vaccine compositions
AU2013201267B2 (en) * 1999-04-09 2016-03-17 Zoetis Services Llc Anti-bacterial vaccine compositions
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
GB9910812D0 (en) 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
PT1350796E (pt) * 2002-04-05 2009-01-23 Merial Sas Bactérias gram-negativas atenuadas
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
CN101496899B (zh) * 2004-08-20 2011-08-24 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
BRPI0519381A2 (pt) * 2004-12-22 2009-01-20 Intervet Int Bv bactÉria atenuada viva de pasteurella multocida, vacina atenuada viva para a proteÇço de animais ou humanos contra infecÇço por pasteurella multocida ou seu efeitos patogÊnicos, uso de uma bactÉria atenuada viva, mÉtodo para a preparaÇço de uma vacina, e, teste diagnàstico para a detecÇço de dna ou rna associado com pasteurella multocida
WO2008118902A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855408A (en) * 1973-07-16 1974-12-17 Univ Minnesota Poultry vaccine
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
US4293545A (en) * 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
ES2059503T5 (es) * 1987-03-24 2000-01-16 Btg International Limited Comp Procedimiento para preparar una vacuna contra pasteurella.
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine
US4999191A (en) * 1988-05-05 1991-03-12 University Of Georgia Research Foundation, Inc. Pasteurella multocida vaccine

Also Published As

Publication number Publication date
CA2148829A1 (en) 1994-05-26
EP0668779A1 (de) 1995-08-30
AU5591694A (en) 1994-06-08
EP0668779A4 (de) 1996-08-21
WO1994011024A1 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
FI100945B (fi) Menetelmä valmistaa Shigella-rokotekanta
JP4179627B2 (ja) コレラワクチンとしての欠失変異体
EP0125228B1 (de) Plasmide und modifizierte Stämme von Vibrio cholerae, ihre Herstellung und davon abgeleitete Vakzine
CN101489584B (zh) 重组减毒梭状芽孢杆菌生物体和疫苗
JP2002521345A (ja) 鳥類病原体を制御するため生きた弱毒化サルモネラワクチン
CA2323634A1 (en) Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles
JPH04504204A (ja) 病原性のないｐｈｏＰ型微生物を含有するワクチン
CN101522210A (zh) 增强免疫应答的组合物和方法
Guidolin et al. Genetics of Vibrio cholerae and its bacteriophages
JPH08503136A (ja) Ｐ．ｍｕｌｔｏｃｉｄａによるパスツレラ症に対する感染防御剤
EP1066376B1 (de) Bakterien abgeschwächt durch einen nicht revertierende mutation in jeden der aroc, ompf und ompc gene, verwendbar als impstoff
JP5745731B2 (ja) サルモネラワクチン
JPH04504656A (ja) ボルデテラワクチン
CN100435845C (zh) 抗猪胸膜肺炎的减毒活疫苗
JP4234232B2 (ja) クロストリジゥムパーフリンジェンスワクチン
JP2004513646A (ja) サルモネラワクチン
JP3388171B2 (ja) 淋菌ｐｉタンパク質およびワクチンの製造
CA2303390C (en) Lkta deletion mutant of p. haemolytica
US5098998A (en) Cholera vaccines and peptides
US5330753A (en) Cholera vaccines
EP0870011A1 (de) Vakzine gegen salmonellen
EP0352250B1 (de) Impfstoff gegen Bordetella pertussis
DE69839161T2 (de) Vibrio cholerae impfstoffkandidaten und verfahren zu deren herstellung
US5470729A (en) Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
DE60037413T2 (de) Rekombinante adhesin-proteine aus haemophilus influenzae